Skip to content

Improving Management and Patient Empowerment using Cloud Technology Among Hypertensive (IMPACT study): A randomised controlled trial

Improving Management and Patient Empowerment using Cloud Technology Among Hypertensive

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14004903
Enrollment
Unknown
Registered
2014-06-27
Start date
2014-07-14
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HYPERTENSION

Interventions

BLOOD PRESSURE MACHINE:taking medication FREE BLOOD PRESSURE PROVIDED
Control:taking no medication

Sponsors

PCCW
Lead Sponsor

Eligibility

Sex/Gender
All
Age
21 Years to 100 Years

Inclusion criteria

Inclusion criteria: Eligible patients are: 1) age being 21 years or older; 2) have had at least two primary care encounters in the 12 months prior to screening with BP higher than 140/90 mm Hg in two separate occasions in the last 3 months; and 4) the average of two consecutive BP measurements taken at the research clinic screening visit being above the goal recommended by the 7th Joint National Commission for the Detection, Evaluation and Treatment of High Blood Pressure (JNC7).

Exclusion criteria

Exclusion criteria: Medical exclusion criteria include the following: the occurrence of known stage 4 or stage 5 kidney disease, acute coronary syndrome, coronary revascularization procedure or stroke within the past three months; known secondary causes of hypertension like coarctation of the aorta, pheochromocytoma, adrenocortical hypertension or renovascular hypertension; class III (marked limitation of physical activity) or IV (symptoms at rest) New York Heart Association classification; or known left ventricular ejection fraction less than 30%. Other additional exclusion criteria: unwillingness to be followed for a period of 18 months; pregnancy or intention to become pregnant in the next two years for females; participation in another clinical trial; spouse having already participated in this study; difficulty with communication in Cantonese; dementia, mental illness or any condition that would limit ability to give informed consent; or upper arm circumference longer than 18 inches (indicating BP cuff on telemonitoring device may not be accurate without modification).

Design outcomes

Primary

MeasureTime frame
Participating patients can improve their self mana;

Countries

China

Contacts

Public ContactPROF. BENJAMIN YIP
benyip@cuhk.edu.hk+852 2252 8799

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026